StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Eupraxia Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $21.33M, up 32.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.33M+32.7%
FY2024Dec 31, 2024$16.08M-21.0%
FY2023Dec 31, 2023$20.36M+49.4%
FY2022Dec 31, 2022$13.63M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?